Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease — Stella

Home/Kartagener Syndrome/

View on ClinicalTrials.gov

Recruiting

Back to Kartagener Syndrome trials

Trial locations(1 site)

United States

The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Key details

Sponsor

University of North Carolina, Chapel Hill

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Enrollment target

~1,800 participants

Started

January 2004

Primary completion

April 2027

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.